Virginia Tech Patents
Permanent URI for this collection
These United States Patents were originally assigned to Virginia Tech.
Browse
Browsing Virginia Tech Patents by Department "Chemistry"
Now showing 1 - 8 of 8
Results Per Page
Sort Options
- Aryl ethynyl phthalic anhydrides and polymers with terminal or pendant amines prepared with aryl ethynyl phthalic anhydrides(United States Patent and Trademark Office, 1996-02-20)Arylethynyl phthalic anhydrides have been synthesized and shown to have particular application as endcappers or pendant groups in high performance/high temperature thermosets which include amine terminal or amine pendant groups.
- Crosslinked polymer compositions, gas separation membranes of such crosslinked polymer compositions, methods of making such membranes, and methods of separating gases using such membranes(United States Patent and Trademark Office, 2017-01-03)Gas separation membrane compositions including at least one crosslinked polymer, gas separation membranes made of such compositions, methods for making such gas separation membranes, and methods of using such membranes to separate gases are described. In one embodiment, the crosslinked polymer includes polyarylene ethers (PAE).
- Inhibiting neurotransmitter reuptake(United States Patent and Trademark Office, 2018-04-17)This document relates to compounds as well as methods and materials involved in modulating neurotransmitter reuptake. For example, compounds, methods for synthesizing compounds, and methods for inhibiting neurotransmitter reuptake are provided. Specifically gamma-amino alcohol derivatives that inhibit the reuptake of neurotransmitters such as dopamine, serotonin, epinephrine or norepinephrine are provided as therapeutic agents for the treatment of depression or anxiety in a mammalian subject.
- Metallic material with low melting temperature(United States Patent and Trademark Office, 1996-04-16)A gallium-indium-zinc-copper metallic material has been found to exhibit many of the advantageous properties of mercury, such as electrical conductivity, fluidity, and high vaporization temperature. The metallic material is formulated by combining individual components in the presence of aqueous base, isolating the metallic phase, and heating the metallic combination. The metallic material is formulated to have sufficient quantities of each of the individual components such that the metallic material has a solidification temperature below 0.degree. C.
- Method for the conversion of cephalomannine to taxol and for the preparation of n-acyl analogs of taxol(United States Patent and Trademark Office, 1995-11-28)The natural product cephalomannine can be converted to the important anticancer natural product taxol by a simple process involving the steps of dihydroxylation to give cephalomannine-diols, diol cleavage, benzoylation at the 2'-position and reaction with a 1,2-diamine. The same process when applied to mixtures of taxol and cephalomannine makes it possible to separate taxol from cephalomannine-diols by simple flash-chromatography after the dihydroxylation step. If the benzoylation step is avoided in the above sequence of conversions, the process leads to the free amine (N-debenzoyltaxol). In addition, the selection of an acylating reagent other than that with the benzoyl group for acylation of the free amine (N-debenzoyltaxol), allows the preparation of taxol analogs with other N-acyl substituents.
- Sphingosine kinase inhibitors(United States Patent and Trademark Office, 2018-10-16)Sphingosine kinases are enzymes that catalyze the biosynthesis of sphingosine-1-phosphate. The invention provides compounds that are effective for inhibition of sphingosine kinase type 1, sphingosine kinase type 2, or both. Certain compounds are selective for sphingosine kinase type 2 relative to sphingosine kinase type 1. Compounds of the invention can be used in treatment of a range of diseases wherein increasing the level of sphingosine-1-phosphate in blood is medically indicated. Diseases that can be treated by administration of an effective dose of a compound of the invention include a neoplastic disease that involves excess vascular growth; macular degeneration or diabetic retinopathy; an allergic disease such as asthma, an inflammatory disease of the eye such as uveitis, scleritis, or vitritis; an inflammatory disease of the kidney; a fibrotic disease; atherosclerosis; or pulmonary arterial hypertension. A compound of the invention can be used to improve the integrity of a vascular barrier in a disease where the vascular barrier is disrupted, such as cancer or Alzheimer's disease.
- Synthesis of sphingosines(United States Patent and Trademark Office, 1996-01-30)Provided by the present invention is a process for the biocatalytic synthesis of optically pure sphingosines from achiral starting material. The stereoisomers of sphingosine are prepared from chiral arene diols using stereospecific reaction techniques to obtain the desired sphingosine or derivative thereof.
- Synthesis of sphingosines(United States Patent and Trademark Office, 1996-01-30)Provided by the present invention is a process for the biocatalytic synthesis of optically pure sphingosines from achiral starting material. The stereoisomers of sphingosine are prepared from chiral arene diols using stereospecific reaction techniques to obtain the desired sphingosine or derivative thereof.